-Robert W Buchanan Researcher Activity Profile

Research Author Detailed Information 

Robert W Buchanan Publication Rate By Year

Robert W Buchanan has published 2 paper(s) in 2006, 8 paper(s) in 2007, 5 paper(s) in 2008, for a total of 15 research publications in total.

Robert W Rw Buchanan Author Information

LAST NAME: buchanan

FIRST NAME: Robert W

INITIALS: rw

AFFILIATION:

Papers

Robert W Buchanan's Publication Record

1. Review of clinical correlates of P50 sensory gating abnormalities in patients with schizophrenia. Year Published: 2006
University of Maryland School of Medicine, Department of Psychiatry, Baltimore, Maryland, USA.
2. Independent domains of inhibitory gating in schizophrenia and the effect of stimulus interval. Year Published: 2007
Maryland Psychiatric Research Center, Department of Psychiatry, University of Maryland School of Medicine, P.O. Box 21247, Baltimore, MD 21228, USA. ehong@mprc.umaryland.edu
3. Neuropsychology of the deficit syndrome: new data and meta-analysis of findings to date. Year Published: 2007
Department of Psychology, University of Maryland, College Park, USA.
4. Recent advances in the development of novel pharmacological agents for the treatment of cognitive impairments in schizophrenia. Year Published: 2007
rwbuchanan@mprc.umaryland.edu
5. The Cognitive and Negative Symptoms in Schizophrenia Trial (CONSIST): the efficacy of glutamatergic agents for negative symptoms and cognitive impairments. Year Published: 2007
Maryland Psychiatric Research Center, University of Maryland School of Medicine, Baltimore, MD 21228, USA.
6. Neuropsychology of the deficit syndrome: new data and meta-analysis of findings to date. Year Published: 2007
Department of Psychology, University of Maryland, College Park, USA.
7. Recent advances in the development of novel pharmacological agents for the treatment of cognitive impairments in schizophrenia. Year Published: 2007
rwbuchanan@mprc.umaryland.edu
8. The Texas medication algorithm project antipsychotic algorithm for schizophrenia: 2006 update. Year Published: 2007
Department of Psychiatry, The University of Texas Health Science Center at San Antonio, USA. mooret3@uthscsa.edu
9. Genetic association and brain morphology studies and the chromosome 8p22 pericentriolar material 1 (PCM1) gene in susceptibility to schizophrenia. Year Published: 2006
Molecular Psychiatry Laboratory, Department of Mental Health Sciences, University College London Medical School, Windeyer Institute of Medical Sciences, London, United Kingdom. h.gurling@ucl.ac.uk
10. The Texas Medication Algorithm Project antipsychotic algorithm for schizophrenia: 2006 update. Year Published: 2007
Department of Psychiatry, The University of Texas Health Science Center at San Antonio, USA. mooret3@uthscsa.edu
11. Galantamine for the treatment of cognitive impairments in people with schizophrenia. Year Published: 2008
Maryland Psychiatric Research Center, P.O. Box 21247, Baltimore, MD 21228. rwbuchanan@mprc.umaryland.edu.
12. Galantamine for the treatment of cognitive impairments in people with schizophrenia. Year Published: 2008
Department of Psychiatry, University of Maryland, Baltimore, MD, USA. rwbuchanan@mprc.umaryland.edu
13. Patterns of cranial, brain and sulcal CSF volumes in male and female deficit and nondeficit patients with schizophrenia. Year Published: 2008
Departamento de Psiquiatría, Hospital General Universitario Gregorio Marañón, Unidad de Adolescentes, Dpto de Psiquiatría, c/ Ibiza 43, Madrid, Spain; Maryland Psychiatric Research Center; University of Maryland School of Medicine, Baltimore, MD, USA.
14. Beta ( approximately 16 Hz) frequency neural oscillations mediate auditory sensory gating in humans. Year Published: 2008
Maryland Psychiatric Research Center, Department of Psychiatry, University of Maryland School of Medicine, Baltimore, Maryland, USA.
15. Galantamine for the treatment of cognitive impairments in people with schizophrenia. Year Published: 2008
Department of Psychiatry, University of Maryland, Baltimore, MD, USA. rwbuchanan@mprc.umaryland.edu